Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2025)

Aurora Cannabis (ACB) reported Liabilities and Shareholders Equity of $556.0 million for Q4 2025, down 10.37% year-over-year from $620.3 million in Q4 2024, and up 1.09% quarter-over-quarter from $550.0 million in Q3 2025.

Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $556.0 million in Q4 2025.

  • Liabilities and Shareholders Equity for Q4 2025 came in at $556.0 million, down 10.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 billion (down 5.88% YoY), and the FY2025 annual result was $594.2 million, down 4.52% from the prior year.
  • Liabilities and Shareholders Equity rose to $556.0 million in Q4 2025 per ACB's latest filing, from $550.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.8 billion in Q3 2021 and troughed at $550.0 million in Q3 2025.
  • A 5-year average of $1.0 billion and a median of $621.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2021 and 2022: Liabilities and Shareholders Equity rose 5.57% in 2021, then tumbled 68.4% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.0 billion in 2021, then sank by 61.75% to $754.3 million in 2022, then dropped by 20.42% to $600.2 million in 2023, then rose by 3.34% to $620.3 million in 2024, then retreated by 10.37% to $556.0 million in 2025.
  • Business Quant data shows ACB's Liabilities and Shareholders Equity at $556.0 million in Q4 2025, $550.0 million in Q3 2025, and $604.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 40.04 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.35 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 2.27 Bn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 401.53 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 555.95 Mn
Sep 30, 2025 549.96 Mn
Jun 30, 2025 604.68 Mn
Mar 31, 2025 594.24 Mn
Dec 31, 2024 620.30 Mn
Sep 30, 2024 592.87 Mn
Jun 30, 2024 613.20 Mn
Mar 31, 2024 622.39 Mn
Dec 31, 2023 600.24 Mn
Sep 30, 2023 610.45 Mn
Jun 30, 2023 619.52 Mn
Mar 31, 2023 685.20 Mn
Dec 31, 2022 754.26 Mn
Sep 30, 2022 897.04 Mn
Jun 30, 2022 850.50 Mn
Mar 31, 2022 1.24 Bn
Dec 31, 2021 1.97 Bn
Sep 30, 2021 2.84 Bn
Jun 30, 2021 2.12 Bn
Mar 31, 2021 2.24 Bn